Marksans Pharma to acquire Netherlands-based QliniQ B.V.
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
Loperamide Hydrochloride is an anti-diarrheal medication used to control symptoms of acute and chronic diarrhoea
The said inspection concluded with Zero Form 483 observation
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Marksans Pharma gets USFDA nod for acid reflux drug
Q4 FY25 PAT stood at Rs. 90.7 crore as compared to Rs.77.6 crore in Q4 FY24
The Subsidiary has received one inspectional observation in Form 483
The products will be manufactured in Goa India and marketed & distributed in Australian markets
Subscribe To Our Newsletter & Stay Updated